Ophthalmology

The treatment was approved in October 2021 and is the first FDA-approved therapy to treat macular edema associated with uveitis via injection to the suprachoroidal space, which provides a more targeted delivery mechanism.

Experts highlight early detection and the goals of therapy when managing patients with glaucoma.

A brief overview of vision preservation in glaucoma and the importance of preventing peripheral vision loss and patient falls.

A recent analysis found a strong negative correlation between plasma THC levels and intraocular pressure in healthy adults after smoking cannabis.

Anne Barmettler, MD, an associate professor of ophthalmology, visual sciences, and plastic surgery at Montefiore Medical Center, outlines adverse events patients taking teprotumumab for thyroid eye disease may experience.

Leon Herndon Jr, MD, a glaucoma specialist, ophthalmologist, and professor of ophthalmology at the Duke University Eye Center, explains how older patients with glaucoma may lose nerve fiber layer at a quicker rate than younger patients.

This represents the approval of the first bispecific antibody to treat wet age-related macular degeneration (AMD) and diabetic macular edema (DME).

A recent study suggests a conceptual deep neural network–based surgical guidance platform is precise and has potential as a valuable tool during phacoemulsification procedures.

Aaron Lee, MD, an associate professor of ophthalmology at the University of Washington, discusses some limitations of artificial intelligence (AI) in the ophthalmology field.

One of the long-term effects of COVID-19 may be small fiber neuropathy in the ocular surface causing similar symptoms to dry eye disease and diabetic neuropathy, a recent study found.

Victoria Ly, MD, MPH, explains potential next steps for her research on vision screening follow-up rate disparities among children in Arkansas.

Recent findings suggest that with more research, anomaly detection may be an option for general retinal disease screening and identification of novel presentations of common retinal diseases.

Judith Lavrich, MD, and Jordan Hamburger outline next steps for their research on virtual learning and pediatric eye health.

A large real-world analysis assessed age-related changes in commonly used visual field reliability indices and the potential mechanisms behind the trends.

One-year outcomes varied among patients with differing neovascular glaucoma etiologies, but many achieved meaningful vision after surgical treatment that included glaucoma drainage devices.

David Ramsey, MD, PhD, MPH, outlines what may have contributed to patients' decisions to return to in-person eye care following a telehealth appointment.

Results of a cross-sectional study highlight features linked with high myopia in Dutch individuals.

James Auran, MD, a professor of ophthalmology at Columbia University Irving Medical Center and president of the American Society of Ophthalmic Trauma, discusses how a lack of providers has created a crisis in the United States.

The top 5 most-read ophthalmology articles of 2021 on AJMC.com evaluated the effectiveness of novel therapies in several ophthalmic diseases, racial/ethnic disparities in clinical trial participation, and the impact of the COVID-19 pandemic on childhood nearsightedness.

Anne Barmettler, MD, an associate professor of ophthalmology, visual sciences, and plastic surgery at Montefiore Medical Center, discusses the cost of teprotumumab for thyroid eye disease.

In India, incidence of the deadly fungal infection grew throughout 2021, while supply chain shortages inhibited optimal treatment for each patient.

Leon Herndon Jr, MD, a glaucoma specialist, ophthalmologist, and professor of ophthalmology at the Duke University Eye Center, explains certain considerations ophthalmologists may need to take into account when treating older patients and the need for more specialists to meet clinical demand.

Results of a retrospective cohort study show youth with type 2 diabetes were almost twice as likely to develop retinopathy compared with those with type 1 diabetes.

Aaron Lee, MD, an associate professor of ophthalmology at the University of Washington, explains why raising the standard of medical knowledge of artificial intelligence (AI) in ophthalmology is important.

Victoria Ly, MD, MPH, outlines one method of tackling vision screening follow-up rate disparities among children in Arkansas.

Using data from the FDA Adverse Event Reporting System, researchers investigated the prevalence of pentosan polysulfate sodium–associated retinal disorders.

Judith Lavrich, MD, and Jordan Hamburger discuss what additional studies need to be carried out in order to better understand the effects of virtual learning on children's long-term eye health.

Study results indicated that measures taken to stem the spread of COVID-19 may have also reduced rates of conjunctivitis, or pink eye.

Pain and fear/anxiety were the most common barriers to anti–vascular endothelial growth factor (VEGF) therapy for neovascular age-related macular degeneration and diabetic macular edema. Another study found that those conditions had a significant impact on patients’ quality of life and Medicare costs.

A new study provides genetic evidence that increased alcohol intake may be a causal risk factor for geographic atrophy, a type of advanced age-related macular degeneration (AMD), but doctors caution it may be too soon to advise patients about the risk.